What Is a GLP-1 Weight Loss Programme?
A GLP-1 weight loss programme is a structured medical intervention that uses glucagon-like peptide-1 (GLP-1) receptor agonist medications — such as Semaglutide (Ozempic/Wegovy) or Tirzepatide (Mounjaro) — alongside diet counselling, metabolic monitoring, and regular physician reviews to help patients achieve meaningful, sustained weight loss.
Unlike over-the-counter diet supplements or generic slimming clinics, a proper GLP-1 programme begins with a thorough medical evaluation: blood tests, cardiovascular screening, HbA1c, fasting insulin, thyroid function, liver enzymes, and body composition analysis. The medication dose is then titrated gradually — starting low and moving up only when it is safe and well-tolerated.
The 'programme' aspect is critical. GLP-1 medications are powerful tools, but they work best when paired with nutritional guidance, physical activity support, and a physician who understands your metabolic history. Without that structure, patients risk poor dosing, unmanaged side effects, or weight regain once medication stops.
How GLP-1 Medications Work
GLP-1 is a natural gut hormone released after eating. It signals the brain to reduce appetite, slows the rate at which food leaves the stomach (gastric emptying), and improves insulin sensitivity. GLP-1 receptor agonists mimic this hormone — but with a longer duration of action than the body's own GLP-1.
The result is that patients feel full sooner, eat less, experience fewer cravings — particularly for high-calorie processed foods — and, over time, lose meaningful body weight.
In landmark clinical trials, semaglutide (STEP-1, NEJM 2021) produced an average body weight reduction of approximately 14.9% over 68 weeks. Tirzepatide (SURMOUNT-1) produced even greater average reductions — up to 20.9% in some arms of the trial.
These outcomes are comparable to results seen with metabolic surgery in carefully selected patients, making GLP-1 therapy one of the most significant developments in non-surgical obesity medicine in decades.
Mounjaro vs. Ozempic — A Quick Comparison
Both medications belong to the GLP-1 class but differ in mechanism. Your doctor at TODS will recommend the most appropriate option based on your medical profile, metabolic markers, existing conditions, and treatment goals. Cost is also a practical consideration.
Mounjaro
Mounjaro activates two metabolic hormone pathways simultaneously — both GLP-1 and GIP receptor pathways. In head-to-head clinical data, Tirzepatide consistently produces greater average weight loss than Semaglutide. Both are available at TODS.
Ozempic
Ozempic is a pure GLP-1 receptor agonist with robust clinical evidence. Generic Semaglutide options are now available in India from approximately ₹325 per weekly injection — though medical supervision remains equally important regardless of brand prescribed.
* Prices are indicative and subject to change. Programme fees — which include consultations, monitoring, and follow-up — are separate and discussed at your assessment.
Who Is a Good Candidate?
GLP-1 therapy is generally appropriate for adults with a BMI of 27.5 or above (the threshold used for South Asian populations). Eligibility is determined through a comprehensive consultation — not a quick online form. A full contraindication review is part of every TODS assessment.
✓You may be a good candidate if…
- ✓BMI of 27.5 or above with at least one weight-related comorbidity
- ✓Diagnosis of type 2 diabetes, hypertension, dyslipidaemia, or sleep apnoea
- ✓Fatty liver disease (NAFLD)
- ✓BMI of 32.5 or above, even without a comorbidity (pending clinical assessment)
- ✓Adult patient committed to lifestyle changes during treatment
✗GLP-1 medications are not appropriate if…
- ✗Personal or family history of medullary thyroid carcinoma
- ✗Multiple Endocrine Neoplasia type 2 (MEN2)
- ✗Severe gastrointestinal disease
- ✗History of pancreatitis
- ✗Currently pregnant or planning pregnancy
What Does the TODS Programme Look Like?
Our four-step programme is built around safety, personalisation, and long-term metabolic health. Every patient is seen, assessed, and managed by qualified physicians committed to evidence-based care.
Comprehensive Medical Assessment
Full blood panel, body composition scan, cardiovascular risk profiling, dietary history, and metabolic evaluation by a senior physician. This takes place at our centre, easily accessible from South Bangalore areas including JP Nagar, Banashankari, and Jayanagar.
Personalised Treatment Plan
Based on your assessment, we determine whether Semaglutide or Tirzepatide is more appropriate, what your starting dose should be, and what your titration schedule will look like over the following weeks.
Ongoing Monitoring
Monthly reviews include weight, blood pressure, blood glucose, side-effect assessment, and dietary adherence. Dosing adjustments are made by the physician — never left to the patient to self-manage without guidance.
Long-Term Planning
We discuss what happens at the end of active therapy — weight maintenance strategies, lifestyle anchoring, and the evidence around medication duration — so that every patient has a realistic roadmap beyond the injection phase.
Why Bangalore Patients Choose TODS
TODS was founded by Dr. Tulip, one of Bangalore's most respected obesity and metabolic surgery specialists. Unlike clinics that have recently added GLP-1 therapy as a side service, TODS was built around obesity medicine from the ground up. Every aspect of our programme — from diagnostic protocols to follow-up structure — reflects clinical best practice.
We are not a weight loss spa. We are not a gym with a doctor on call. We are a dedicated obesity medicine centre where every patient is seen, assessed, and managed by qualified physicians committed to evidence-based care.
Built for Obesity Medicine
TODS was built around obesity medicine from the ground up — not a side service. Every protocol reflects clinical best practice.
Flexible Scheduling
IT professionals from Whitefield and Electronic City get flexible appointment times. Working professionals from HSR Layout and BTM Layout get a programme that fits demanding schedules.
Plain-Language Care
Homemakers from Rajajinagar and Malleshwaram find a doctor who speaks plainly about treatment options — no jargon, no pressure.
Evidence-Based Protocols
Every decision — from initial assessment to dose titration to exit planning — is grounded in peer-reviewed clinical evidence.
Continuous Monitoring
Monthly reviews track weight, blood pressure, blood glucose, and dietary adherence. Adjustments are made by physicians, not algorithms.
Long-Term Roadmap
Every patient leaves with a realistic plan beyond the injection phase — maintenance strategies, lifestyle anchoring, and exit planning built in.
Risks, Side Effects, and What to Watch For
GLP-1 medications are well tolerated by most patients, particularly when doses are titrated gradually. The most common side effects are gastrointestinal in nature: nausea, vomiting, constipation, or diarrhoea. These are generally mild and transient, and tend to improve after the first few weeks.
Rare but serious considerations include pancreatitis, gallbladder disease, and — in theoretical animal models — thyroid C-cell effects (the clinical relevance in humans is still under study). This is precisely why a proper medical evaluation before starting treatment, and regular monitoring during it, is not optional — it is essential.
Common side effects (most are mild & transient)
At TODS, our doctors provide detailed pre-treatment counselling so that patients know exactly what to expect, when to contact the clinic, and when a symptom warrants early review. Self-medicating with GLP-1 injections purchased online — without evaluation or monitoring — is something we strongly advise against.
Real-World Outcomes: What to Expect
Clinical trial results are an average across large populations. In practice, individual weight loss varies. Most patients in a well-supervised programme can expect 5–15% body weight reduction over 6–12 months, with the higher end of that range more achievable with Tirzepatide in adherent patients.
Weight Loss: 5–15% body weight over 6–12 months
The higher end of this range is more achievable with Tirzepatide in adherent patients. Results depend on starting weight, metabolic profile, lifestyle adherence, and medication choice.
Improved HbA1c and Blood Glucose Control
Meaningful improvements in blood sugar levels are often among the earliest benefits seen — particularly important for patients with type 2 diabetes or prediabetes.
Lower Blood Pressure and Improved Lipids
Cardiovascular risk markers frequently improve significantly, often well before the most dramatic weight changes occur.
Reduced Liver Fat and Better Sleep Quality
Patients with fatty liver disease (NAFLD) and sleep apnoea often see meaningful functional improvements — outcomes that are personally significant beyond the numbers on a scale.
— TODS Medical Team
Frequently Asked Questions
Everything you need to know about GLP-1 therapy, eligibility, costs, and what to expect at TODS.
Serving All of Bangalore
TODS serves patients across Bangalore — including JP Nagar, Jayanagar, Koramangala, BTM Layout, HSR Layout, Electronic City, Marathahalli, Whitefield, Indiranagar, Banashankari, Rajajinagar, Malleshwaram, Yelahanka, and Hebbal.
Whether you are a busy professional from the tech corridor or a resident of South Bangalore's residential neighbourhoods, we offer flexible consultation scheduling designed around your life.
⚕ Medical Review Notice
This article has been reviewed for clinical accuracy by the medical team at Dr. Tulip's Obesity & Diabetes Surgery Centre. The information provided is for educational purposes and does not constitute personalised medical advice. Please consult a qualified physician before beginning any weight loss programme.
Dr. Tulip
Specialist in Obesity Medicine, Bariatric Surgery, and Metabolic Health — TODS India, Bangalore. Dr. Tulip is one of Bangalore's most respected obesity and metabolic surgery specialists, with deep expertise in non-surgical obesity interventions including GLP-1 therapy, alongside surgical options for eligible patients.
Ready to Find Out If a GLP-1 Programme Is Right for You?
Book a comprehensive medical assessment at TODS today. Our team will evaluate your health profile, explain your options, and build a personalised plan — with no pressure and full transparency.